Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels

The American Journal of Cardiology
Romuald WojniczMarius M Rozek

Abstract

This study evaluated the safety, tolerability, and efficacy of statin therapy in patients with heart failure secondary to inflammatory dilated cardiomyopathy and moderately elevated low-density lipoprotein cholesterol levels. Seventy-four patients were randomized to receive atorvastatin 40 mg/day or conventional treatment for heart failure. After 6 months of therapy, the predefined primary efficacy end point (an increase of >5% in the absolute left ventricular ejection fraction and > or =2 selected criteria by echocardiography and a decrease in New York Heart Association functional class) was significant in the statin-treated patients (p = 0.004). Among secondary efficacy parameters, the quality-of-life index showed a trend suggesting the benefit of statin therapy (p = 0.055). In conclusion, the results of this study demonstrate that treatment with atorvastatin in addition to standard therapy for heart failure may significantly improve clinical outcomes in this cohort of patients.

Citations

Aug 19, 2007·Heart Failure Reviews·Sofia G TsouliMoses S Elisaf
Jul 9, 2008·Current Atherosclerosis Reports·Stuart D Katz
May 29, 2013·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·M CorrealeN D Brunetti
Sep 17, 2011·QJM : Monthly Journal of the Association of Physicians·M AlbertonE J Mills
Mar 31, 2007·International Journal of Clinical Practice·K Z GongZ G Zhang
Jan 19, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuhiro MaejimaUNKNOWN Heart Failure by Coadministration of Statin and Angiotensin-II Receptor Blocker (HF-COSTAR) Trial Investigators
Jul 9, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Takayoshi TsutamotoMinoru Horie
Jun 29, 2013·Vascular Health and Risk Management·Kwadwo Osei BonsuDaniel Diamond Reidpath
Sep 12, 2013·Pharmacology & Therapeutics·Dimitris TousoulisChristodoulos Stefanadis
Dec 7, 2007·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Pim van der HarstDirk J van Veldhuisen
Nov 28, 2013·Current Atherosclerosis Reports·Luisa De GennaroMatteo Di Biase
Sep 14, 2014·Heart Failure Clinics·John G F ClelandAndrew Clark
Jan 8, 2011·Expert Opinion on Investigational Drugs·Agata Bielecka-DabrowaMaciej Banach
Feb 12, 2014·The American Journal of Cardiology·Gang LiuXiao-Hong Huang
Dec 28, 2011·International Journal of Cardiology·Hisato Takagi, Takuya Umemoto
Sep 20, 2011·European Journal of Internal Medicine·Shuning ZhangJunbo Ge
Oct 26, 2010·International Journal of Cardiology·Senthil K ThambidoraiSyed M Mohiuddin
Mar 31, 2009·Journal of Cardiac Failure·Maral OuzounianDouglas S Lee
Jun 27, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Zeljko Reiner
Apr 25, 2008·Heart Failure Clinics·Bobby V Khan, Sanjay Rajagopalan
Apr 1, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Pablo F CastroSergio Lavandero
Oct 17, 2012·Congestive Heart Failure·Mark R KahnTimothy J Vittorio
Dec 8, 2009·The American Journal of Cardiology·Michael J LipinskiGeorge W Vetrovec
Sep 26, 2007·American Heart Journal·Jeffrey G ShanesSean A Tabaie
Aug 23, 2006·The American Journal of Cardiology·Kaizheng GongZhengang Zhang
Nov 16, 2007·Expert Opinion on Pharmacotherapy·Tamara B Horwich, W Robb MacLellan
Aug 7, 2007·Journal of the American College of Cardiology·Valerio ZacàHani N Sabbah
Dec 19, 2006·Journal of the American College of Cardiology·W H Wilson Tang, Gary S Francis
Jan 29, 2008·Journal of the American College of Cardiology·Kumudha RamasubbuDouglas L Mann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.